期刊文献+

卷积法在体内外相关性研究中的应用 被引量:10

Application of numerical convolution in in vivo/in vitro correlation research
原文传递
导出
摘要 本文介绍了体内外相关性和卷积法/反卷积法的概念及原理,阐述了采用卷积法使用Excel根据制剂的药代动力学数据计算其在体内释放行为的策略及方法,并用于体内外相关性研究。该法用数学软件对药代动力学数据进行拟合以弥补缺失的数据点,在假设输入函数基本符合威布尔规律的前提下,在Excel中根据卷积法原理以试错法的方式确定拟合度最佳的输入函数(威布尔函数)参数,最后以拟合度最佳的输入函数作为制剂的体内释放行为与体外释放数据进行相关性研究。在实例中不仅详细说明了该法的应用,并且通过与隔室模型法和反卷积法的比较证明此方法简单有效,可以作为体内外相关性研究的有力工具。 This paper introduced the conception and principle of in vivo / in vitro correlation (IVIVC) and convolution / deconvolution methods, and elucidated in details the convolution strategy and method for calculating the in vivo absorption performance of the pharmaceutics according to the their pharmacokinetic data in Excel, then put the results forward to IVIVC research. Firstly, the pharmacokinetic data ware fitted by mathematical software to make up the lost points. Secondly, the parameters of the optimal fitted input function were defined by trail-and-error method according to the convolution principle in Excel under the hypothesis that all the input functions fit the Weibull functions. Finally, the IVIVC between in vivo input function and the in vitro dissolution was studied. In the examples, not only the application of this method was demonstrated in details but also its simplicity and effectiveness were proved by comparing with the compartment model method and deconvolution method. It showed to be a powerful tool for IVIVC research.
作者 岳鹏
出处 《药学学报》 CAS CSCD 北大核心 2009年第1期19-24,共6页 Acta Pharmaceutica Sinica
关键词 卷积法 体内外相关性 EXCEL convolution in vivo / in vitro correlation Excel
  • 相关文献

参考文献10

  • 1US Pharmacopeia 31 (2007), ( 1088)In vitro and In vivo evaluation of dosage forms.
  • 2Emami J. In vitro - in vivo correlation: from theory to applications [J]. J Pharm Pharm Sci, 2006, 9: 169-189.
  • 3Gillespie WR. Convolution-based approaches for in vivo - in vitro correlation modeling [J]. Adv Exp Med Biol, 1997, 423: 53-65.
  • 4O'Hara T, correlation Hayes S, Davis J, et al. In vivo - in vitro (IVIVC) modeling incorporating a convolution step [J]. J Pharmacokinet Pharmacodyn, 2001, 28: 277-298.
  • 5Gaynor C, Dunne A, Davis J. A comparison of the prediction accuracy of two IVIVC modeling techniques [J]. J Pharm Sci, 2008, 97: 3422-3432.
  • 6YuJ ZouMJ DengCX etal.Evaluation of in vitro / in vivo correlation for propafenone hydrochloride sustained release pellets using deconvolution method .药学学报,2007,42:20-25.
  • 7杨明世,游本刚,杨明华,寸冬梅,陶安进,崔福德.脱卷积法进行自制尼群地平缓释制剂体内外相关性研究[J].药学学报,2004,39(9):738-741. 被引量:17
  • 8YinLL LiuXH JinL etal.Evaluation of in vitro / in vivo correlation for metformin hydrochloride sustained- release tablets by deconvolution method .中国药剂学杂志,2006,4:170-175.
  • 9Langenbucher E Handling of computational in vitro / in vivo correlation problems by microsoft excel: Ⅲ. Convolution and deconvolution [J]. Eur J Pharm Biopharm, 2003, 56: 429-437.
  • 10Ma Y. Study on tetrandrine calcium alginate sustained release gel beads [D]. Shenyang: Shenyang Pharmaceutical University, 2003.

二级参考文献5

  • 1Balan G, Timmins P, Greene DS, et al. In vitro-in vivo correlation models for metformin after administration of modified-release oral dosage forms to healthy human volunteers [ J]. J Pharm Sci, 2001,90(8): 1176 - 1185.
  • 2Krol GJ, Lettieri JT, Yeh SC, et al. Disposition and pharmacokinetics of 14C-nitrendipine in healthy volunteers [J]. J Cardiovasc Pharmacol, 1987,9(Suppl 4) :S122-S128.
  • 3Langenbucher F, Mysicka J. In vitro and in vivo deconvolution assessment of drug release kinetics from oxprenolol oros preparations [J]. Br J Clin Pharmacol,1985,19:151S - 162S.
  • 4Wagner JG. Do you need a pharmacokinetic method, and if so, which one? [J] J Pharmacokin Biopharm, 1975,3(6) :457-478.
  • 5Vaughan DP, Nennis M. Mathematical basis of pointarea deconvolution method for determining in vivo input functions [J]. J Pharm Sci, 1978,67(5) :663 -665.

共引文献16

同被引文献118

引证文献10

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部